Are we overestimating the penetrance of mutations in SDHB?
Francesca Schiavi(Istituto Oncologico Veneto), Alberto Cascón(Spanish National Cancer Research Centre), Emma Anda(Complejo Hospitalario de Navarra), Roger L. Milne(The University of Melbourne), Maurizio Castellano(Brescia University), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Pilar Blay(Instituto de Investigación Sanitaria del Principado de Asturias), Giuseppe Opocher(University of Padua)
Cited by 65
Related Papers
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
|Nature Communications|2020|694
MicroRNA Related Polymorphisms and Breast Cancer Risk
|PLoS ONE|2014|638
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528